Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin

Xenotransplantation

Volumn 20, Issue 2, 2013, Pages 75-81

  Mueller, Kate R ^a,d   Balamurugan, A N ^a   Cline, Gary W ^b   Pongratz, Rebecca L ^b   Hooper, Rebecca L ^a   Weegman, Bradley P ^a   Kitzmann, Jennifer P ^a   Taylor, Michael J ^c   Graham, Melanie L ^a   Schuurman, Henk Jan ^a   Papas, Klearchos K ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Cell and Tissue Systems Inc   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

human; islets; nonhuman primate; nutrient stimulated insulin secretion; pig; species incompatibility

Indexed keywords

INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PREDICTIVE VALUE; PRIMATE; PRIORITY JOURNAL; SAFETY; XENOTRANSPLANTATION;

ANIMALS; CELL COUNT; CELL SIZE; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PRIMATES; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875772087     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/xen.12022     Document Type: Article

References (31)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011. Available at http://www.srtr.org/annual-reports/2010. Accessed 29June12.
2. Tuttle-Newhall JE, Krishnan SM, Levy MF, McBride V, Orlowski JP, Sung RS,. Organ donation and utilization in the United States, 1998-2007. Am J Transplant 2009; 2009 (9): 879-893.
3. Wolfe RA, Merion RM, Roys EC, Port FK,. Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant 2009; 9: 869-878.
4. CITR Annual Report (December 20, 2011) https://web.emmes.com/study/isl/ reports/reports.htm
5. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301-303.
6. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
7. Thompson P, Cardona K, Russell M, et al. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant 2011; 11: 947-957.
8. Cardona K, Milas Z, Strobert E, et al. Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant 2007; 7: 2260-2268.
9. Thompson P, Badell IR, Lowe M, et al. Islet xenotranplantation using Gal-deficient neonatal donors improves engraftment and function. Am J Transplant 2011; 11: 2593-2602.
10. van der Windt DJ, Bottino R, Casu A, et al. Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 2009; 9: 2716-2726.
11. Hecht G, Eventov-Friedman S, Rosen C, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proc Natl Acad Sci USA 2009; 106: 8659-8664.
12. Dufrane D, Goebbels RM, Gianello P,. Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression. Transplantation 2010; 90: 1054-1062.
13. Casu A, Bottino R, Balamurugan AN, et al. Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice. Diabetologia 2008; 51: 120-129.
14. Graham ML, Bellin MD, Papas KK, Hering BJ, S chuurman HJ: species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011; 18: 328-342.
15. Balamurugan AN, Ramakrishna B, Gunasekaran S,. Insulin secretory characteristics of monkey pancreatic islets: a simple method of islet isolation and the effect of various density gradients on separation. Diabetes Res Clin Pract 2004; 66: 13-21.
16. Colton CK, Papas KK, Pisania A, et al. Characterization of islet preparations. In:, Halberstadt C, Emerich DF, eds. Cell Transplantation from Laboratory to Clinic. New York: Elsevier, 2007; 85-132.
17. Purified Human Pancreatic Islets Master Production Batch Record (Product Code PHPI-A-01) (CIT Protocols 03-07). http://www.isletstudy.org/CITDocs/ SOP%203101,%20B01,%20MPBR%20v05,%20October%2028,%202010.pdf. Accessed September 13, 2012.
18. Papas KK, Graham ML, Avgoustiniatos S, et al. Quality assessment as a predictor for graft function in the pig-to-nonhuman primate islet transplantation model [Abstract]. Xenotransplantation 2011; 18: 299-300.
19. Papas KK, Pisania A, Wu H, Weir GC, Colton CK,. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets. Biotechnol Bioeng 2007; 98: 1071-1082.
20. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant 2007; 7: 707-713.
21. Papas KK, Suszynski TM, Colton CK,. Islet assessment for transplantation. Curr Opin Organ Transplant 2009; 14: 674-682.
22. Papas KK, Colton CK, Qipo A, et al. Prediction of marginal mass required for successful islet transplantation. J Invest Surg 2010; 23: 28-34.
23. Wijkstrom M, Kenyon NS, Kirchhof N, et al. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720. Transplantation 2004; 77: 827-835.
24. Taylor MJ, Baicu S, Greene E, Vazquez A, Brassil J,. Islet isolation from juvenile porcine pancreas after 24-h hypothermic machine perfusion preservation. Cell Transplant 2010; 19: 613-628.
25. Pongratz RL, Kibbey RG, Kirkpatrick CL, et al. Mitochondrial dysfunction contributes to impaired insulin secretion in INS-1 cells with dominant-negative mutations of HNF-1alpha and in HNF-1alpha-deficient islets. J Biol Chem 2009; 284: 16808-16821.
26. Colton CK,. Implantable biohybrid artificial organs. Cell Transplant 1995; 4: 415-436.
27. Ludwig B, Rotem A, Schmid J, et al. Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist. Proc Natl Acad Sci USA 2012; 109: 5022-5027.
28. Avgoustiniatos ES, Colton CK,. Effect of external oxygen mass transfer resistances on viability of immunoisolated tissue. Ann NY Acad Sci 1997; 831: 145-167.
29. Wu H, Avgoustiniatos ES, Swette L, Bonner-Weir S, Weir GC, Colton CK,. In situ electrochemical oxygen generation with an immunoisolation device. Ann NY Acad Sci 1999; 875: 105-125.
30. Avgoustiniatos ES, Colton CK,. Design considerations in immunoisolation. In:, Lanza RP, Langer R, Chick WL, Landes RG, eds. Principles of Tissue Engineering. San Diego, CA: Academic Press, 1997; pp 333-346.
31. Avgoustiniatos ES, Wu H, Colton CK,. Engineering in immunoisolation device development. In:, Lanza RP, Langer R, Chick WL, eds. Principles of Tissue Engineering. 2nd edn. San Diego, CA: Academic Press, 2000; 331-350.